Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
Sponsor: Bordeaux Colorectal Institute Academy
Summary
The objective of this prospective international cohort is to evaluate the LUMENEYE rectoscope for assessment on tumor response after total neoadjuvant treatment in rectal cancer. Patients included in this study will be patients who initially will be good candidates for organ preservation. The participating centers are all expert centers in tumor assessment. All patient assessments after neoadjuvant treatment for rectal adenocarcinoma will be included in each centre.
Official title: Prospective Study Incorporating LUMENEYE Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-01-04
Completion Date
2025-09
Last Updated
2025-09-12
Healthy Volunteers
No
Conditions
Interventions
International Cohort
Assessing tumour response following neoadjuvant treatment in rectal cancer include : * Digital rectal examination * Rectal MRI * Rectoscopy ( Lumeneye device) The monitoring of tumour response intervals up to 6 months following completion of the neoadjuvant treatment at 8 weeks, at 16 weeks, at 24 weeks after the end of neoadjuvant treatment.
Locations (8)
Clinique Tivoli-Ducos - Bordeaux Colorectal Institute
Bordeaux, France
Hôpital Européen de Marseille
Marseille, France
Hôpital Saint-Antoine - APHP
Paris, France
CHU de ROUEN
Rouen, France
Humanitas Research Hospital
Milan, Italy
Amsterdam UMC
Amsterdam, Netherlands
University Hospital Vall D'Hebron
Barcelona, Spain
Imperial College London
London, United Kingdom